* As of Jan 4 – D. E. Shaw & Co. L.P. Reports 5 Pct Passive
Stake In Biocryst Pharmaceuticals Inc SEC filing
Source text for Eikon:
Further company coverage:
The post BRIEF-D. E. Shaw & Co reports 5 pct passive stake in Biocryst pharma- sec filing appeared first on NASDAQ.